Tag: Columbus Venture Partners
Polypeptide Therapeutic Solutions acquired by Arcline Investment
Arcline Investment Management has acquired Polypeptide Therapeutic Solutions (PTS), a Spanish manufacturer of polyaminoacid-based drug delivery systems, from Columbus Venture Partners. The financial terms of ... Read More
Aura Biosciences raises $80m for VDC therapies for cancers
Aura Biosciences, a portfolio company of UK-based Arix Bioscience, has raised $80 million in a new funding round for developing virus-like drug conjugate (VDC) therapies ... Read More